#iqvia — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #iqvia, aggregated by home.social.
-
In our “The future of life sciences R&D” series, IQVIA’s Niamh McGuinness, PhD, examines why AI success hinges on the quality and structure of scientific content. Using drug discovery and biomarker research, she shows how connected, traceable knowledge enables deeper, reliable inquiry and builds the groundwork for agentic AI.
Read the full interview here: https://www.techfinitive.com/opinions/why-ai-still-struggles-to-answer-rds-most-important-questions/
-
In our “The future of life sciences R&D” series, IQVIA’s Niamh McGuinness, PhD, examines why AI success hinges on the quality and structure of scientific content. Using drug discovery and biomarker research, she shows how connected, traceable knowledge enables deeper, reliable inquiry and builds the groundwork for agentic AI.
Read the full interview here: https://www.techfinitive.com/opinions/why-ai-still-struggles-to-answer-rds-most-important-questions/
-
In our “The future of life sciences R&D” series, IQVIA’s Niamh McGuinness, PhD, examines why AI success hinges on the quality and structure of scientific content. Using drug discovery and biomarker research, she shows how connected, traceable knowledge enables deeper, reliable inquiry and builds the groundwork for agentic AI.
Read the full interview here: https://www.techfinitive.com/opinions/why-ai-still-struggles-to-answer-rds-most-important-questions/
-
In our “The future of life sciences R&D” series, IQVIA’s Niamh McGuinness, PhD, examines why AI success hinges on the quality and structure of scientific content. Using drug discovery and biomarker research, she shows how connected, traceable knowledge enables deeper, reliable inquiry and builds the groundwork for agentic AI.
Read the full interview here: https://www.techfinitive.com/opinions/why-ai-still-struggles-to-answer-rds-most-important-questions/
-
In our “The future of life sciences R&D” series, IQVIA’s Niamh McGuinness, PhD, examines why AI success hinges on the quality and structure of scientific content. Using drug discovery and biomarker research, she shows how connected, traceable knowledge enables deeper, reliable inquiry and builds the groundwork for agentic AI.
Read the full interview here: https://www.techfinitive.com/opinions/why-ai-still-struggles-to-answer-rds-most-important-questions/